Shares of Zee Entertainment surged over 15% following the approval from NCLT for the Zee-Sony Merger.
Today, the broader indices, such as Nifty 50 and BSE Sensex, concluded the day in the red, even though the RBI kept the repo rate unchanged at 6.5%.
The Nifty50 index opened the day at 19,605.55, nearly unchanged from the previous day’s closing level of 19,632. It eventually concluded the day at 19,543, marking a decrease of 89.45 from the previous closing. Meanwhile, the BSE Sensex closed at 65,688, down by 307.63 points from the previous day’s closing level.
In this article, we will explore the stocks that have reached new 52-week highs, taking into consideration the company’s previous 52-week prices recorded in the year 2022.
| Company Name | CMP | % Change | New 52-week High Price | Prv. 52-Week High Price | Prv. 52-Week High Price Date |
|---|---|---|---|---|---|
| Hindustan Composites Limited | 444.65 | 20.00 | 444.65 | 416.00 | 15-Sep-22 |
| Zee Entertainment Enterprises Limited | 281.45 | 16.18 | 290.70 | 287.00 | 06-Oct-22 |
| Jubilant Pharmova Limited | 447.50 | 11.94 | 470.00 | 423.90 | 09-Dec-22 |
Hindustan Composites Limited is involved in the creation, production, and promotion of brake linings, utilizing asbestos industrial products and friction materials. Additionally, since 2010, the company has been active in the treasury sector.
Today, the company’s shares surged by 20%, concluding the session at Rs 444.65 on NSE. The company’s market capitalization stands at Rs 656 Crore. During FY23, the company’s revenue experienced a growth of 21.5%, rising from Rs 233 Crore to Rs 283 Crore. The company achieved an Operating Profit of Rs 41 Crore, with an operating profit margin of 14%. In FY23, the net profit amounted to Rs 27 Crore. The company’s ROCE and ROE are notably low at 3.55% and 3.00%, respectively. Notably, the stock has generated a return of 50% over the past three months.
Promoter holding in the company is 74.97%, DIIs hold 0.01%, whereas public investors hold 25%.
Zee Entertainment Enterprises Limited primarily operates within the following sectors as Satellite Television Channel Broadcasting, serving as a space-selling agent for other satellite television channels, and engaging in the distribution of media content, including programs, film rights, feeds, and music rights.
Today, the company’s shares surged by 16%, culminating in the session at Rs 281.45 on NSE. The company currently boasts a market capitalization of Rs 27,428 Crore. Despite this, the company’s revenue experienced a slight dip of 1.25% in FY23, decreasing from Rs 8,189 Crore to Rs 8,088 Crore. The company achieved an Operating Profit of Rs 1,107 Crore, maintaining an operating profit margin of 14%. During FY23, the net profit for the company amounted to Rs 48 Crore. It’s important to note that both its ROCE and ROE are remarkably low, standing at 7.96% and 0.71%, respectively. Impressively, the stock has yielded a return of 48% over the past three months.
The company’s promoter holding in the company at 3.99%, while DIIs and FIIs hold 33.40% and 40.62%, respectively. Public investors account for the remaining 21.85% ownership stake.
Jubilant Pharmova Limited is an integrated global pharmaceutical company with three business segments those are pharmaceuticals, contract research, and development services, and proprietary novel drugs.
Today, the company’s shares surged by 12%, concluding the session at Rs 447.5 on NSE. The market capitalization of the company currently stands at Rs 7,182 Crore. The company witnessed revenue growth of 2.5% in FY23, ascending from Rs 6,130 Crore to Rs 6,282 Crore. The company achieved an Operating Profit of Rs 776 Crore, maintaining an operating profit margin of 12%. However, in FY23, the company reported a net loss of Rs 65 Crore. Over the past three months, the stock has generated a noteworthy return of 32%.
The company’s promoter holding is at 50.67%, while DIIs and FIIs hold 23.20% and 1.63%, respectively. Public investors account for the remaining 23.91% ownership stake.